More Telix Pharmaceuticals Limited news
Telix Pharmaceuticals LimitedASX: TLX

Renal Cancer Collaboration with Memorial Sloan Kettering

Dec 13, 2017 at 9:56 PM EST · Issued by Telix Pharmaceuticals Limited

Filed with ASX · Dec 13, 2017 at 9:56 PM EST · 2 pages · English

On 6ix: 6ix.com/news/renal-cancer-collaboration-with-memorial-sloan-kettering

Watch Telix Pharmaceuticals' latest call↗Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call↗

Telix Pharmaceuticals Limited on 6ix

Earlier from Telix Pharmaceuticals

  • Manufacturing Partnership with JFE Engineering CorporationDec 12, 2017
  • Admission to Official ListNov 15, 2017

Later from Telix Pharmaceuticals

  • Telix establishes Japanese subsidiaryJan 15, 2018
  • Appendix 4C - December 2017 quarterJan 29, 2018
  • Shareholder UpdateFeb 21, 2018
  • Appendix 4E and 2017 Annual ReportFeb 25, 2018
  • Telix and Radboud University Medical Centre CollaborationMar 14, 2018
All Telix Pharmaceuticals news releases↗

Follow Telix Pharmaceuticals into a list and get an email when it puts out news.

Follow Telix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer